Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2026-02-28 @ 5:31 AM
Study NCT ID:
NCT01016093
Status:
UNKNOWN
Last Update Posted:
2011-07-26
First Post:
2009-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
Sponsor:
Tehran University of Medical Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HORCSCT-0601
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mahdi Jalili MD / Hematology-Oncology and SCT Research Center
Old Organization:
Tehran University of Medical Sciences
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |